Table 7. KIR2DL3 and Group 1 HLA-C Associations in the Spontaneously Resolving Cohort.
Resolved n (%) | Persistent n (%) | P Value (Pc) | OR (95% CI) | |
---|---|---|---|---|
Number of patients | 122 | 219 | ||
KIR2DL3 and HLA-C alleles | ||||
2DL3+Cw*01 | 7 (5.7) | 10 (4.6) | 0.42 | |
2DL3+Cw*03 | 38 (31.2) | 42 (19.2) | 0.01 (0.08) | 1.9 (1.1-3.2) |
2DL3+Cw*07 | 70 (57.4) | 115 (52.5) | 0.38 | |
2DL3+Cw*08 | 12 (8.2) | 11 (5.0) | 0.09 (>0.1) | 2.06 (0.82-5.21) |
2DL3+Cw*12 | 11 (9.0) | 13 (5.9) | 0.26 | |
2DL3+Cw*14 | 1 (0.8) | 3 (1.4) | 0.65 | |
2DL3+Cw*16 | 10 (8.2) | 18 (8.2) | 0.99 | |
KIR2DL3 number and HLA-Cw*03 | ||||
2DL2/2DL3+Cw*03 | 14 (11.4) | 20 (9.1) | 0.49 | |
2DL3/2DL3+Cw*03 | 23 (18.9) | 20 (9.1) | 0.01 (0.02) | 2.3 (1.2-4.4) |